longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS

PRTCY

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 178.50, above the reasonable range, cheaper than 2.17% of the time in the past 1 years, and the industry ranks 67/603, the industry Median -2.26.

178.5xP/E
$15.39Stock price
$0.09Earnings per share
178.5xP/E
Stock price$15.39Earnings per share$0.09

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-3.69x
Typical range
-3.86x–-3.57x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
04590135180

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
BMRNUSBioMarin Pharma
159.85x52.85%$11.66B
YDESUSYD Bio
1,327.60x--$405.93M
PRTCYUSPURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS
178.50x--$377.34M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.